Literature DB >> 19533267

Pathological influence of obesity on renal structural changes in chronic kidney disease.

Shigeko Kato1,2, Arifa Nazneen1, Yumiko Nakashima1, Mohammed S Razzaque1, Tomoya Nishino3, Akira Furusu3, Noriaki Yorioka4, Takashi Taguchi5.   

Abstract

BACKGROUND: Role of obesity in renal pathological and structural changes remains poorly investigated, and this study was designed to examine the pathological effects of obesity on renal structural components in patients with chronic kidney diseases (CKD).
METHODS: The study subjects were obese (body mass index, BMI > or = 25 kg/m2) patients with nonglomerulonephritis (non-GN, n = 26), IgA nephropathy (IgAN, n = 19), benign nephrosclerosis (BNS, n = 15), and thin basement membrane disease (TMD, n = 6), and 65 nonobese controls (n = 20, 20, 10, and 15, respectively). Patients were evaluated for glomerular lesions (mesangial proliferation and focal segmental/global glomerulosclerosis), glomerular size, and thickness of glomerular basement membrane (GBM).
RESULTS: Urinary protein was higher in obese non-GN, IgAN, and BNS groups than in the respective controls. Focal segmental glomerulosclerosis (FSGS) lesions were noted in all obesity groups. The glomeruli were larger in size in obese than in nonobese patients of the non-GN and IgAN groups. The glomeruli of nonobese TMD and BNS patients were significantly larger in size than those of nonobese non-GN patients. GBM were thicker in obese than in nonobese patients irrespective of types of glomerular diseases, but only significantly so in non-GN and BNS groups.
CONCLUSION: In non-GN, IgAN, and BNS, obesity worsens proteinuria and is associated with structural changes such as glomerulomegaly and GBM thickening, similar to changes observed in obesity-related nephropathy. Obesity seems to worsen the renopathological state in CKD.

Entities:  

Mesh:

Year:  2009        PMID: 19533267     DOI: 10.1007/s10157-009-0169-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  24 in total

1.  Glomerular morphometry in biopsy evaluation of minimal change disease, membranous glomerulonephritis, thin basement membrane disease and Alport's syndrome.

Authors:  Charan Singh Rayat; Kusum Joshi; Pranab Dey; Vinay Sakhuja; Ranjana Walker Minz; Usha Datta
Journal:  Anal Quant Cytol Histol       Date:  2007-06       Impact factor: 0.302

2.  Differential expression of nephrin according to glomerular size in early diabetic kidney disease.

Authors:  Jin-Ju Kim; Jin Ji Li; Dong-Sub Jung; Seung-Jae Kwak; Dong-Ryeol Ryu; Tae-Hyun Yoo; Seung Hyeok Han; Hoon Young Choi; Hyung Jong Kim; Dae Suk Han; Shin-Wook Kang
Journal:  J Am Soc Nephrol       Date:  2007-06-28       Impact factor: 10.121

Review 3.  Epidemiology of obesity and chronic kidney disease.

Authors:  Will R Ross; Janet B McGill
Journal:  Adv Chronic Kidney Dis       Date:  2006-10       Impact factor: 3.620

Review 4.  Pathogenesis of diabetic nephropathy.

Authors:  A E Raptis; G Viberti
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

5.  Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.

Authors:  Yichao Wu; Zhihong Liu; Zhaoying Xiang; Caihong Zeng; Zhaohong Chen; Xiaojing Ma; Leishi Li
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

6.  Functional and structural changes in the kidney in the early stages of obesity.

Authors:  Jeffrey R Henegar; Steven A Bigler; Lisa K Henegar; Suresh C Tyagi; John E Hall
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

7.  Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.

Authors:  Sheldon Chen; Joseph S Lee; M C Iglesias-de la Cruz; Amy Wang; Adriana Izquierdo-Lahuerta; Nisha K Gandhi; Farhad R Danesh; Gunter Wolf; Fuad N Ziyadeh
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

8.  A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition.

Authors:  R A Stahl; F Thaiss; U Wenzel; W Schoeppe; U Helmchen
Journal:  J Am Soc Nephrol       Date:  1992-05       Impact factor: 10.121

9.  Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.

Authors:  Marina Aunapuu; Ulle Pechter; Andres Arend; Toivo Suuroja; Mai Ots
Journal:  Medicina (Kaunas)       Date:  2003       Impact factor: 2.430

10.  Renal injury in the extremely obese patients with normal renal function.

Authors:  A Serra; R Romero; D Lopez; M Navarro; A Esteve; N Perez; A Alastrue; A Ariza
Journal:  Kidney Int       Date:  2008-01-23       Impact factor: 10.612

View more
  19 in total

Review 1.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice.

Authors:  Mutsuko Ohnishi; Shigeko Kato; M Shawkat Razzaque
Journal:  Biochem Biophys Res Commun       Date:  2011-10-20       Impact factor: 3.575

3.  Resveratrol Protects Against Renal Damage via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice.

Authors:  Kang Cheng; Zhihua Song; Yanan Chen; Simian Li; Yuying Zhang; Hao Zhang; Lili Zhang; Chao Wang; Tian Wang
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

4.  Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.

Authors:  Quan-Lan Jasmine Lew; Tazeen Hasan Jafar; Mohammad Talaei; Aizhen Jin; Khuan Yew Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Kidney Int       Date:  2017-05-18       Impact factor: 10.612

Review 5.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

6.  Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters.

Authors:  Hiroshi Kataoka; Mamiko Ohara; Kaori Shibui; Masayo Sato; Tomo Suzuki; Nobuyuki Amemiya; Yoshihiko Watanabe; Kazuho Honda; Takahiro Mochizuki; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-02-17       Impact factor: 2.801

Review 7.  Scope and mechanisms of obesity-related renal disease.

Authors:  Tracy E Hunley; Li-Jun Ma; Valentina Kon
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

8.  High-calorie diet results in reversible obesity-related glomerulopathy in adult zebrafish regardless of dietary fat.

Authors:  Evan M Zeitler; J Charles Jennette; Jennifer E Flythe; Ronald J Falk; John S Poulton
Journal:  Am J Physiol Renal Physiol       Date:  2022-02-28

9.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

10.  Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy.

Authors:  Nobuo Tsuboi; Kentaro Koike; Keita Hirano; Yasunori Utsunomiya; Tetsuya Kawamura; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2012-11-08       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.